The Whole Truth
Science & Research
Latest Research
Go Back
Jun 22, 2006
Interim results of a phase I clinical trial administering Zyflamend® to subjects
[ Download PDF ]
Pierorazio P, Masson P, Cammack S, Capodice J, Goluboff E, Stone BA, McKiernan JM, Benson

Subjects diagnosed with prostatic intraepithelial neoplasia (PIN) at prostate biopsy are at
increased risk of developing prostate cancer on later biopsies.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.